dianhydrogalactitol has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finklestein, JZ; Hammond, D; Higgins, G; Krivit, W; Shore, N | 1 |
2 other study(ies) available for dianhydrogalactitol and Thrombopenia
| Article | Year |
|---|---|
Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Deoxyguanosine; Dianhydrogalactitol; Drug Evaluation; Humans; Leukopenia; Pancreatic Neoplasms; Piperazines; Razoxane; Sugar Alcohols; Thionucleosides; Thrombocytopenia; Triazines | 1985 |
Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
Topics: Child; Dianhydrogalactitol; Drug Evaluation; Hemorrhage; Humans; Leukemia; Leukopenia; Neoplasms; Sugar Alcohols; Thrombocytopenia | 1985 |